| Income Statement |
| Operating Expenses | -2.30M |
|
| Research and Development Expense | 999.00K |
| Selling, General and Administrative Expense | 4.77M |
| Operating Income | 2.30M |
| Interest Expense | 7.56M |
| Net Income | 1.39M |
| Net Income Common Stock | 1.39M |
| Net Income Common Stock (USD) | 1.39M |
| Consolidated Income | 1.28M |
| Net Income to Non-Controlling Interests | 107.00K |
| Earnings per Basic Share | 0.01 |
| Earnings per Basic Share (USD) | 0.01 |
| Earnings per Diluted Share | 0.01 |
| Earning Before Interest & Taxes (EBIT) | 8.94M |
| Earning Before Interest & Taxes (USD) | 8.94M |
| Weighted Average Shares | 163.90M |
| Weighted Average Shares Diluted | 173.67M |
| Balance Sheet |
| Cash and Equivalents | 99.72M |
| Cash and Equivalents (USD) | 99.72M |
| Investments | 654.48M |
| Investments Non-Current | 654.48M |
| Trade and Non-Trade Receivables | 46.11M |
| Current Assets | 147.86M |
| Property, Plant & Equipment Net | 350.16M |
| Total Assets | 1.15B |
| Debt Current | 251.01M |
| Total Debt | 251.01M |
| Current Liabilities | 311.84M |
| Total Liabilities | 312.93M |
| Accumulated Retained Earnings (Deficit) | -734.76M |
| Accumulated Other Comprehensive Income | -3.49M |
| Shareholders Equity | 788.52M |
| Shareholders Equity (USD) | 788.52M |
| Assets Non-Current | 1.00B |
| Total Debt (USD) | 251.01M |
| Liabilities Non-Current | 1.09M |
| Trade and Non-Trade Payables | 60.83M |
| Tax Assets | 11.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 115.00K |
| Net Cash Flow from Financing | 731.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.28M |
| Capital Expenditure | -3.00K |
| Net Cash Flow - Business Acquisitions and Disposals | 6.33M |
| Issuance (Purchase) of Equity Shares | 802.00K |
| Issuance (Repayment) of Debt Securities | -71.00K |
| Net Cash Flow from Investing | 6.33M |
| Net Cash Flow from Operations | -4.71M |
| Effect of Exchange Rate Changes on Cash | -66.00K |
| Share Based Compensation | 4.09M |